Skip to main content
Clinical Trials/NCT00925223
NCT00925223
Unknown
Not Applicable

Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients

Shandong University0 sites30 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Irritable Bowel Syndrome
Sponsor
Shandong University
Enrollment
30
Last Updated
16 years ago

Overview

Brief Summary

Brain-derived neurotrophic factor (BDNF), originally known to be a member of the nerve growth factor family, has aroused attention as a modulator in visceral hyperalgesia recently. Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients. So in this study, the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
November 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shandong University

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with irritable bowel syndrome.

Exclusion Criteria

  • Patients have similar clinical symptoms as IBS, yet there is morphologic changes in the intestine.

Outcomes

Primary Outcomes

Not specified

Similar Trials